Scynexis (SCYX) Profit After Tax (2013 - 2026)
Scynexis' (SCYX) quarterly Profit After Tax came in at -$21.3 million in Q1 2026, down 295.08% YoY from $10.9 million in Q1 2025, and down 273.76% on a QoQ basis from $12.3 million in Q4 2025.
Scynexis (SCYX) Profit After Tax (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Profit After Tax data on file, last reported at -$21.3 million in Q1 2026.
- Quarterly Profit After Tax fell 295.08% year-over-year to -$21.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.5 million (up 9.5% YoY) and the FY2025 annual result came in at -$8.6 million, up 59.56% from the prior year.
- Profit After Tax eased to -$21.3 million in Q1 2026, from $12.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $122.3 million in Q2 2023 to a low of -$33.9 million in Q1 2023.
- A 5-year average of -$2.8 million and a median of -$6.9 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 4789.92% — and 2023, when it soared 1016.15%.
- Tracing SCYX's Profit After Tax over 5 years: stood at -$14.4 million in 2022, then sank by 35.74% to -$19.6 million in 2023, then soared by 77.37% to -$4.4 million in 2024, then soared by 376.52% to $12.3 million in 2025, then plunged by 273.76% to -$21.3 million in 2026.
- The last three Profit After Tax figures came in at -$21.3 million (Q1 2026), $12.3 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 60.95 Mn | -53.74 Mn | - | 7.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.40 Mn |
| Mar 31, 2026 | -21.30 Mn |
| Dec 31, 2025 | 12.26 Mn |
| Sep 30, 2025 | -8.59 Mn |
| Jun 30, 2025 | -6.89 Mn |
| Mar 31, 2025 | -5.39 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -14.46 Mn |
| Mar 31, 2024 | 411,000.00 |
| Dec 31, 2023 | -19.59 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | 122.26 Mn |
| Mar 31, 2023 | -33.88 Mn |
| Dec 31, 2022 | -14.43 Mn |
| Sep 30, 2022 | -29.58 Mn |
| Jun 30, 2022 | -13.35 Mn |
| Mar 31, 2022 | -5.45 Mn |
| Dec 31, 2021 | -29.28 Mn |
| Sep 30, 2021 | -605,000.00 |